Latest Darwin Global Management, Ltd. Stock Portfolio
Darwin Global Management, Ltd. Performance:
2025 Q2: 23.23%YTD: 35.16%2024: 3.49%
Performance for 2025 Q2 is 23.23%, and YTD is 35.16%, and 2024 is 3.49%.
About Darwin Global Management, Ltd. and 13F Hedge Fund Stock Holdings
In it's latest 13F Holdings report, Darwin Global Management, Ltd. reported an equity portfolio of $2.4 Billions as of 30 Jun, 2025.
The top stock holdings of Darwin Global Management, Ltd. are INSM, VRNA, CDTX. The fund has invested 80.8% of it's portfolio in INSMED INC and 16.3% of portfolio in VERONA PHARMA PLC.
Darwin Global Management, Ltd. opened new stock positions in CIDARA THERAPEUTICS INC (CDTX) and MERUS N V (MRUS). The fund showed a lot of confidence in some stocks as they added substantially to INSMED INC (INSM), VERONA PHARMA PLC (VRNA) and ALLOGENE THERAPEUTICS INC (ALLO).
The top stock holdings of Darwin Global Management, Ltd. are INSM, VRNA, CDTX. The fund has invested 80.8% of it's portfolio in INSMED INC and 16.3% of portfolio in VERONA PHARMA PLC.
Darwin Global Management, Ltd. opened new stock positions in CIDARA THERAPEUTICS INC (CDTX) and MERUS N V (MRUS). The fund showed a lot of confidence in some stocks as they added substantially to INSMED INC (INSM), VERONA PHARMA PLC (VRNA) and ALLOGENE THERAPEUTICS INC (ALLO).
Darwin Global Management, Ltd. Annual Return Estimates Vs S&P 500
Our best estimate is that Darwin Global Management, Ltd. made a return of 23.23% in the last quarter. In trailing 12 months, it's portfolio return was 33.81%.
New Buys
| Ticker | $ Bought |
|---|---|
| cidara therapeutics inc | 37,998,600 |
| merus n v | 20,970,200 |
New stocks bought by Darwin Global Management, Ltd.
Additions
| Ticker | % Inc. |
|---|---|
| insmed inc | 25.63 |
| verona pharma plc | 5.26 |
| allogene therapeutics inc | 0.29 |
Additions to existing portfolio by Darwin Global Management, Ltd.
Reductions
Sold off
Sector Distribution
Darwin Global Management, Ltd. has about 100% of it's holdings in Healthcare sector.
| Sector | % |
|---|---|
| Healthcare | 100 |
Market Cap. Distribution
Darwin Global Management, Ltd. has about 80.8% of it's portfolio invested in the large-cap and mega-cap stocks.
| Category | % |
|---|---|
| LARGE-CAP | 80.8 |
| MID-CAP | 17.1 |
| MICRO-CAP | 1.6 |
Stocks belong to which Index?
About 81.3% of the stocks held by Darwin Global Management, Ltd. either belong to S&P 500 or RUSSELL 2000 index.
| Index | % |
|---|---|
| RUSSELL 2000 | 81.3 |
| Others | 18.7 |
Darwin Global Management, Ltd. Holdings Map
This heatmap illustrates the top 50 positions within the fund's portfolio.
Current Stock Holdings of Darwin Global Management, Ltd.
Darwin Global Management, Ltd. has 5 stocks in it's portfolio. ALLO proved to be the most loss making stock for the portfolio. INSM was the most profitable stock for Darwin Global Management, Ltd. last quarter.
Last Reported on: 14 Aug, 2025| Ticker | Namesorted ascending | % Portfolio | Shares Held | $ Value | Type | % Change | Options | |
|---|---|---|---|---|---|---|---|---|
| ALLO | allogene therapeutics inc | 0.52 | 10,479,800 | 12,366,200 | added | 0.29 | ||
| CDTX | cidara therapeutics inc | 1.59 | 768,424 | 37,998,600 | new | |||
| INSM | insmed inc | 80.75 | 19,344,600 | 1,924,600,000 | added | 25.63 | ||
| MRUS | merus n v | 0.88 | 395,738 | 20,970,200 | new | |||
| VRNA | verona pharma plc | 16.26 | 4,129,620 | 387,441,000 | added | 5.26 | ||